The world has been here before — a hemorrhagic fever outbreak simmering undetected for weeks, then confirmed too late for easy containment. What happened in West Africa between 2014 and 2016, killing more than 11,000 people and infecting more than 28,000, began the same way. Now, new CDC modeling suggests the current outbreak of Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda carries a disturbingly similar trajectory if intervention efforts fall short.
The analysis, published June 11, 2026, in the Morbidity and Mortality Weekly Report (MMWR) by Eric Q. Mooring and colleagues at CDC’s Center for Forecasting and Outbreak Analytics, offers a stark probabilistic portrait of where this outbreak is headed. Using a branching process transmission model calibrated to publicly available situation reports, the team simulated hundreds of possible outbreak trajectories under varying assumptions about current death counts and intervention intensity. The results make a compelling case for treating this response as a maximum-effort public health emergency.
What the Models Reveal About an Already-Large Outbreak
When only 20% of symptomatic individuals are successfully identified, isolated, and treated, the model projects that 65% of simulations result in 20,000 or more cumulative cases within three months, with nearly 70% projecting more than 4,000 deaths. Even a moderate isolation rate of 50% still yields a 17% chance of exceeding 20,000 cases and a 22% chance of surpassing 4,000 deaths.
The picture shifts meaningfully only when isolation reaches 70% or higher. At that threshold, assuming 50 confirmed deaths as of May 24, the proportion of simulations projecting more than 10,000 cases drops to just 6%, with only 3% projecting more than 4,000 deaths. Put plainly, the model identifies 70% case isolation as a rough inflection point between a manageable epidemic and a potential catastrophe. The challenge is that 70% is an ambitious benchmark under field conditions in northeastern DRC, an area with significant logistical, infrastructure, and security constraints.
The model also inferred that the likely zoonotic spillover event occurred in mid-to-late February 2026 — weeks before the outbreak was formally detected in May. That lag matters enormously. Research cited in the report establishes that delayed recognition of Ebola outbreaks is positively correlated with larger and longer epidemics. The DRC’s national public health institute recorded only 10 confirmed deaths as of May 24, alongside 223 suspected deaths — a discrepancy that captures the core uncertainty driving the model’s three calibration scenarios of 50, 100, and 200 cumulative deaths. As the assumed death count rises, the projected scale of the outbreak grows correspondingly worse, even under high isolation scenarios.
The Biosecurity Stakes: A Response Comparable to 2014–2016
Mooring and colleagues explicitly state that the public health effort needed to control this outbreak will likely need to be comparable in magnitude to the 2014–2016 West Africa Ebola response, one of the most resource-intensive international health emergency mobilizations ever undertaken. That response involved billions of dollars in emergency funding, thousands of international responders, and coordination across dozens of governments and agencies.
No approved vaccine or therapeutic currently exists for Bundibugyo virus, distinguishing this outbreak from more recent Zaire ebolavirus events where ring vaccination has been a cornerstone of response. That absence raises the stakes for the non-pharmaceutical interventions that remain available: rapid case identification, aggressive contact tracing, safe and dignified burials, and community engagement. Each of these is labor-intensive, culturally sensitive, and dependent on trust infrastructure that takes time to build.
CDC has maintained its assessment that risk to the general U.S. population remains low. That judgment holds, but the report notes that even during the unprecedented 2014–2016 epidemic, two transmission events occurred in the United States among health care workers. Port-of-entry screening, health education, and risk assessment protocols implemented during that period remain in place, but the volume and intensity of the current outbreak warrant continued vigilance in monitoring traveler-associated risk.
Limitations That Shape the Analysis
The true number of BVD deaths through May 24 remains uncertain, and confirmed case counts likely underrepresent actual transmission. The basic reproductive number (R0) estimated in this analysis, with a median of approximately 2.51, is consistent with prior Ebola outbreaks but may not precisely reflect this virus’s behavior in these specific communities and conditions. The model also does not account for the potential for relapses in recovered individuals — a documented phenomenon in Ebola that could sustain transmission chains over longer periods. These omissions suggest that projections over windows beyond three months should be interpreted with additional caution.
What the model does do well is define the decision space clearly. The margin between a contained epidemic and a historically large one is narrow and depends heavily on the speed and scale of isolation capacity.
Sources and further reading:
Mooring EQ et al. Modeled Scenario Projections for the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026. MMWR Morbidity and Mortality Weekly Report. June 11, 2026.